COCH Gene Deafness Autosomal Dominant Type 9 Genetic Test
At DNA Labs UAE, we offer the COCH Gene Deafness Autosomal Dominant Type 9 Genetic Test at a cost of AED 4400.0.
Test Details
The COCH gene is associated with a condition called deafness, autosomal dominant type 9 (DFNA9). DFNA9 is a form of genetic hearing loss that is inherited in an autosomal dominant pattern, meaning that an affected individual has a 50% chance of passing on the condition to each of their children.
Our NGS (Next-Generation Sequencing) technology allows us to analyze multiple genes simultaneously, including the COCH gene. By sequencing the COCH gene, we can identify any disease-causing variants or mutations that may be present.
Components
- Test Name: COCH Gene Deafness Autosomal Dominant Type 9 Genetic Test
- Price: AED 4400.0
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Ear Nose Throat Disorders
- Doctor: ENT Doctor
- Test Department: Genetics
- Pre Test Information: Clinical History of Patient who is going for EYA1 Gene Branchiootic syndrome type 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with EYA1 Gene Branchiootic syndrome type 1 NGS Genetic DNA Test gene EYA6
Importance of Genetic Testing
The COCH Gene Deafness Autosomal Dominant Type 9 Genetic Test can help confirm a diagnosis of DFNA9 in individuals with suspected hearing loss. It can also be used for carrier testing in family members of affected individuals, providing important information for genetic counseling, family planning, and potentially guiding treatment options in the future.
It’s important to note that genetic testing should always be conducted under the guidance of a healthcare professional or genetic counselor who can interpret the results and provide appropriate counseling and support.
| Test Name | COCH Gene Deafness autosomal dominant type 9 Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Ear Nose Throat Disorders |
| Doctor | ENT Doctor |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for EYA1 Gene Branchiootic syndrome type 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with EYA1 Gene Branchiootic syndrome type 1 NGS Genetic DNA Test gene EYA6 |
| Test Details | The COCH gene is associated with a condition called deafness, autosomal dominant type 9 (DFNA9). DFNA9 is a form of genetic hearing loss that is inherited in an autosomal dominant pattern, meaning that an affected individual has a 50% chance of passing on the condition to each of their children. NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technology to analyze multiple genes simultaneously. In the case of DFNA9, an NGS genetic test would involve sequencing the COCH gene to look for any disease-causing variants or mutations. This type of genetic testing can help confirm a diagnosis of DFNA9 in individuals with suspected hearing loss and can also be used for carrier testing in family members of affected individuals. It can provide important information for genetic counseling, family planning, and potentially guide treatment options in the future. It’s important to note that genetic testing should always be conducted under the guidance of a healthcare professional or genetic counselor who can interpret the results and provide appropriate counseling and support. |
